Novo Nordisk and AWS bring agentic AI into drug discovery
Novo Nordisk is increasing its use of AWS synthetic intelligence instruments throughout drug discovery, together with AI brokers for goal identification, remedy design, and analysis workflows. Under the settlement introduced not too long ago, AWS will grow to be Novo Nordisk’s most popular cloud supplier and strategic AI associate. The corporations have additionally created a…
